Investornewsbreaks Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement To Acquire Italian Biotech Pincell
Scinai Immunotherapeutics (NASDAQ: SCNI) , announced it has signed a binding option agreement to acquire Pincell srl, an Italian biotech developing P ...
Le Lézard10d
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. , a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and in providing CDMO services through its Scinai Bioservices unit, ...
Scientists use alpaca antibodies to make new pandemic flu drug
Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZeneca.
heraldsun.com.au23d
Australia’s first dedicated cardiac hospital: A place where lives are saved
The cricket ground was only minutes from the new Victorian Heart Hospital (VHH) in Clayton. In Toussaint’s cricket team was a former policeman who was a trained medic who just happened to have a ...